NCT01348334

Brief Summary

The purpose of this study is to determine the clinical results contributions to surgical success,and complications of mixed type of mesh materials as well as prolen mesh materials in sling surgery in a 3 year follow-up the first time in literature.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2004

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2004

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2007

Completed
3.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2010

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 28, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 5, 2011

Completed
Last Updated

May 5, 2011

Status Verified

July 1, 2004

Enrollment Period

3 years

First QC Date

April 28, 2011

Last Update Submit

May 4, 2011

Conditions

Keywords

Sling surgerysynthetic meshesultrapromesh®mix meshincontinenceThe Ultrapromesh® synthetic sling procedures have lower complications incidence and higher success rates than the other synthetic slings in 3-year follow-up.

Outcome Measures

Primary Outcomes (1)

  • continence rates at three years after surgery

    Ultrapromesh® with its superior biomechanical characteristics and with its high success rates,low vaginal and urethral extrusion and denovo urgency rates determined in clinical studies,can be reliably and effectively used in sling surgery.

    three years after surgery

Secondary Outcomes (5)

  • urethral erosion at three years after surgery

    three years after surgery

  • vaginal erosion at three years after surgery

    three years after surgery

  • Denovo urgency at three years after surgery

    three years after surgery

  • urine retantion at three years after surgery

    three years after surgery

  • sutur granuloma at three years after surgery

    three years after surgery

Study Arms (3)

Vypromesh®(Ethicon,USA)

ACTIVE COMPARATOR

Vypromesh®(semiabsorbable multiflament mesh;non-absorbable Polypropylene+absorbable Poliglactin)

Procedure: Synthetic sling surgery

Ultrapromesh®(Ethicon,USA)

ACTIVE COMPARATOR

Ultrapromesh®(semiabsorbable monofilament mesh;non-absorbable Polypropylene+absorbable polyglecaprone).

Procedure: Synthetic sling surgery

Prolene light mesh®(Johnson&Johnson,USA)

ACTIVE COMPARATOR

Prolene light mesh®(cpp-Condensed monofilament non absorbable polypropylene mesh)

Procedure: Synthetic sling surgery

Interventions

An incision of inverted A shape was inflicted on the anterior vaginal wall(AVW)of the vagina.The upper part of A shaped incision was formed into an island belonging to the vaginal wall.This patch was 3×4cm in most of the patients.Proximal AVWwas dissected as a flap.Synthetics mesh materials were first sutured onto the upper part of the A on the vaginal island with absorbable vicrly sutures.Then,with 2polypropilen sutures,these meshes were fixed on both the right and left sides of this island in a helical manner to form a suspension and using curved Kishner needles,the prolene sutures were transferred to suprapubic area.These sutures were ligated on the rectus fascia in a crosswise manner.The mobile lower wing was advanced onto the island and was sutured onto the vaginal skin with intermittent sutures using 3-0 monocryl sutures.After cystoscopy,the prolene sutures were ligated crosswise in the suprapubic region.Special attention was paid notto create much tension on the mesh material.

Prolene light mesh®(Johnson&Johnson,USA)Ultrapromesh®(Ethicon,USA)Vypromesh®(Ethicon,USA)

Eligibility Criteria

Age31 Years - 75 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stress urinary incontinence
  • Mix urinary incontinence
  • Previous failed anti-incontinence surgery
  • Previous gynecologic surgery

You may not qualify if:

  • Urodynamical detrusor overactivity or impaired bladder activity
  • Prolaps of pelvic organ
  • Urge incontinence
  • Neurogenic bladder
  • Bladder outlet obstruction
  • Urinary fistula, Pregnancy
  • Active urinary or vaginal enfection
  • Contraindication to anesthesia
  • \> 100ml PVR urine volume

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Carter E, Johnson EE, Still M, Al-Assaf AS, Bryant A, Aluko P, Jeffery ST, Nambiar A. Single-incision sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2023 Oct 27;10(10):CD008709. doi: 10.1002/14651858.CD008709.pub4.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 28, 2011

First Posted

May 5, 2011

Study Start

July 1, 2004

Primary Completion

July 1, 2007

Study Completion

November 1, 2010

Last Updated

May 5, 2011

Record last verified: 2004-07